Trial Profile
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2023
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Aspirin
- Indications Embolism; Stroke
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms ARCADIA; Arcadia CSI (Cognition And Silent Infarcts)
- 06 Jun 2023 Status changed from active, no longer recruiting to discontinued.
- 15 Dec 2022 Status changed from recruiting to active, no longer recruiting.
- 26 Mar 2022 Planned End Date changed from 1 Apr 2022 to 1 Jun 2024.